What's Next for Abbott Laboratories' Stock?

With a 10-year return of 378% handily beating the market's gain of 282%, Abbott Laboratories (NYSE: ABT) is a stock that many investors dream about. Between its steadily rising dividend payout, a constant flow of new consumer health products, and the power of being one of the biggest healthcare companies in the world, it's easy to see why -- and all those pluses could make shareholders richer over time.

But can it continue to stay innovative and lucrative as an investment in the face of competitors encroaching and economic winds changing? Yes, probably, and here's why.

Image source: Getty Images.

Source Fool.com